Oral delivery of systemic monoclonal antibodies, peptides and small molecules using gastric auto-injectors
A Nature Biotechnology paper on a swallowable liquid auto-injector that delivers up to 4 mg of drug into the stomach wall, with bioavailability up to 80% and peak blood levels within 30 minutes.
A Nature Biotechnology paper on a swallowable liquid auto-injector that delivers up to 4 mg of drug into the stomach wall, with bioavailability up to 80% and peak blood levels within 30 minutes. In pigs it delivered adalimumab, a GLP-1 analogue, insulin and epinephrine.
